Associated Papers
Overexpression of P-glycoprotein and MRP-1 are pharmacogenomic biomarkers to determine steroid resistant phenotype in childhood idiopathic nephrotic syndrome.
Prasad N et al.
The Pharmacogenomics Journal, 2021
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics.
Koller D et al.
Advances in Therapy, 2021
33278020 (PubMed )
Supplement: 12325_2020_1566_MOESM1_ESM.docx
MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.
Xiao Z et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2017
Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.
Yin G et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2016
The single nucleotide polymorphism and haplotype analysis of MDR1 in Chinese diffuse large B cell lymphoma patients.
Ni Y et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2015
The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China.
Qiu H et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2012
MDR-1 gene polymorphisms in steroid-responsive versus steroid-resistant nephrotic syndrome in children.
Jafar T et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 2011
Select a paper to view details